Resultados de la búsqueda 1111-1120 of 7000 for Genetic Counseling
Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma.
A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS ...
NGS is a procedure that looks at relevant cancer associated genes and what they do. Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer ...
The purpose of this study is to see if having different kinds of bacteria genes in breast tissue may be connected to the risk of getting breast cancer. A ...
This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), and bone ...
This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta ...
This rare genetic condition causes weight gain, extra fingers or toes, kidney conditions, vision loss, and changes in development.
The purpose of this study is to demonstrate haemorrhage detection sensitivity >80% and specificity >80%. Testing the Addition of an Anti-cancer Drug, Selinexor, ...
... genes for their role in tumor biology. Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results ...
This study includes two study visits if you are a healthy or heart failure volunteer. All testing will be performed at our testing center at St. Mary's Hospital ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?